Navigation Links
Cytos VLP Platform is Basis for Phase 1 Clinical Trial with Anti-IgE Vaccine
Date:2/3/2013

ZURICH, February 4, 2013 /PRNewswire/ --

Cytos Biotechnology Ltd (SIX:CYTN) has been informed by Pfizer Inc. that the first patient has been dosed in a Phase 1 clinical trial with an anti-IgE vaccine, which is being developed under a license agreement between both parties. Pfizer's anti-IgE vaccine is based on Cytos' VLP ("virus-like-particle") vaccine platform.

Christian Itin , Chairman and Chief Executive Officer of Cytos, comments: "We are very pleased that Pfizer has advanced its anti-IgE vaccine to a Phase 1 clinical trial. This is an important milestone for the program and provides further evidence of the potential of Cytos' B-cell vaccine platform based on Qbeta-derived virus like particles."

Pfizer acquired world-wide exclusive rights to develop, manufacture and commercialize certain specified vaccines based on Cytos' VLP platform in 2009.

About Cytos Biotechnology Ltd

Cytos is a public biopharmaceutical company focused on the development of targeted immuno-therapies. The Company's lead product candidate CYT003 is a first-in-class biologic in Phase 2 clinical development as a potential new treatment for allergic asthma.

CYT003 acts via a novel, allergen-independent mechanism of action to selectively suppress the body's immune response to allergens, a predominant risk factor for asthma. In a successfully completed Phase 2a study, CYT003 was shown to maintain asthma control and lung function and asthma control in patients with persistent allergic asthma, even as standard inhaled corticosteroid treatment was withdrawn. CYT003 has been shown to be safe in over 450 patients to date.

Cytos was founded in 1995 as a spinoff from the Swiss Federal Institute of Technology (ETH) in Zurich. It is located in Schlieren (Zurich), Switzerland. The Company is listed according to the Main Stan
'/>"/>

SOURCE Cytos
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cytos Biotechnology Ltd Reports Third Quarter 2012 Financial Results, Recent Development and Outlook
2. CytoSorbents Receives Approximately $400,000 in Non-Dilutive Capital from the Sale of Net Operating Loss Carryovers
3. Guangzhous Sun Yat-sen University Cancer Center Debuts MOSAIQ in the Chinese Platform
4. Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform
5. Simbionix Releases Two New Platforms at the Upcoming DDW and AUA Events
6. Mylan Sponsors Drug Store News and Pharmacist Society to Provide a New Business Networking Platform for Pharmacy Schools and Students
7. Aushon to Launch New Multiplex Immunoassay Platform
8. ZyDoc Selects Health Fidelitys REVEAL™ Natural Language Processing (NLP) Platform to Accelerate Time to Value for its MediSapien Web Services
9. iBio Announces Important Expansion of its Intellectual Property Portfolio: Allowance of Patent for Anthrax Vaccines and Further Application of Modulator Platform
10. Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production
11. WaferGen Bio-systems Launches MyDesign - Setting a New Standard in Flexibility with an Open Format High-Throughput qPCR Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)...  Tandem Diabetes Care®, Inc. (NASDAQ: TNDM ... t:slim® and t:flex™ Insulin Pumps, today announced the pricing ... its common stock at a price to the public ... from this offering are expected to be $56.3 million, ... offering expenses payable by Tandem. All of the shares ...
(Date:2/26/2015)... BEND, Ind. , Feb. 26, 2015  Mobility ... announce an agreement with Bank of America (NYSE: ... consumers nationwide to receive financing of the revolutionary MV-1 ... vehicle, designed from the ground up to provide safe ... Approved applicants can use their loan to purchase a ...
(Date:2/26/2015)... DALLAS , February 26, 2015 ... EU Outlook 2015: First -In- Class Innovations and ... Business for Large Cap Pharmaceutical Companies research report ... According to this Global Pharma US ... divested as productivity measurements, divestment of non-core assets ...
Breaking Medicine Technology:Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 4
... 28, 2012   OncoSec Medical Incorporated (OTCBB: ONCS), ... ElectroOncology therapies to treat solid tumor cancers, today announced ... by the University of California San Francisco and the ... clinical trial evaluating OncoSec,s OMS ElectroImmunotherapy for ...
... from visual impairment due to autism, brain injury, stroke or ... a revolutionary new therapy program using specially designed games and ... Therapy Program uses a web-based application in which patients ... system dysfunction and strengthen visual skills. The application was created ...
Cached Medicine Technology:OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma 2OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma 3OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma 4New Therapy Program Allows Doctors to Prescribe Computer Games on iPad to Treat Visual Impairment 2
(Date:2/27/2015)... 2015 RDI-Engineering will be hosting an ... event on March 14, at Moreno Valley College. The ... how to use engineering software and tools, and a ... by Moreno Valley College’s Upward Bound Math and Science ... in hopes to encourage students to seek educational and ...
(Date:2/27/2015)... Canadian, Oklahoma (PRWEB) February 27, 2015 ... run by the U.S. Drug Enforcement Agency (DEA). ... with local organizations continue to utilize the “Take-Back” ... listed by the FDA. , Eufaula Prescription Drug ... designated 1425 Industrial Drive in Eufaula, Oklahoma as ...
(Date:2/27/2015)... Philanthropy is a continuous force restoring people’s ... help to restore that faith by helping the people in ... husband/wife Realtor team gives to the local children in need ... while others have been added as the need arose. , ... haven and counseling for women who have suffered physical and ...
(Date:2/27/2015)... San Mateo, CA (PRWEB) February 27, 2015 ... five 2015 California Teachers of the Year. The gala ... helping all their students achieve both in and outside ... grade science instructor at Manhattan Beach Middle School, was ... , As the Presenting Sponsor of the California ...
(Date:2/27/2015)... Austin, TX (PRWEB) February 27, 2015 ... University 3D printing survey is to explore the current ... economy. You are invited to contribute to the Survey ... Preliminary results reveal varied use among large and ... categories of companies. In a recent PwC and Manufacturing ...
Breaking Medicine News(10 mins):Health News:RDI-Engineering Participates in STEM”U”LATE Your Mind Event to Host Educational Exhibition 2Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 2Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 3Health News:Mr. And Mrs. Smits Proves That Altruism Works All Year Round 2Health News:California Casualty is Presenting Sponsor of California Program Honoring Educators That Make a Difference 2Health News:California Casualty is Presenting Sponsor of California Program Honoring Educators That Make a Difference 3Health News:Survey of Texas Manufacturers, Technology, Life Sciences and Innovation Companies Reveals Broad, Varied Interest and Skills Shortage in 3D Printing Applications Says NAU 2Health News:Survey of Texas Manufacturers, Technology, Life Sciences and Innovation Companies Reveals Broad, Varied Interest and Skills Shortage in 3D Printing Applications Says NAU 3
... egg should be avoided by patients with high cholesterol ... has developed a egg variety that does no ... diabetes is growing especially in Indian sub-continent. 'The modified ... S.K. Taneja, a professor in the university's Department of ...
... are increasingly recognized as important factors in disease ... drug resistance. However, the distinction of co-infecting site ... been // ficult with traditional methods based on ... ,Trypanosoma brucei , a protozoan parasite transmitted by ...
... can be used to reveal the strength of bones ... the likelihood of fracturing a particular bone, an article ... says. ,Scientists have developed a laser imaging technique ... density thereby predicting future risk of fracturing that particular ...
... from Italy have found a new urine test which detects ... test which is proved to be 90% accurate is used ... of patients. The results of the study have been published ... would be very useful for detecting cancer in smokers and ...
... perception is dependent on the specialized cells of the eye. ... a research state that our perception of color is controlled ... ,The number of color-sensitive cones in the human retina differs ... perceive colors the same way. The study has shown that ...
... In a novel initiative to combat the spread of ... joint initiative// of the William J. Clinton Foundation and ... entered into a partnership with Nickelodeon's award-winning Let's Just ... forces on a comprehensive media and public awareness campaign, ...
Cached Medicine News:Health News:Fluorescent markers to distinguish Trypanosoma brucei strains causing Sleeping Sickness 2Health News:Urine testing for telomerase enzyme for bladder cancer diagnosis 2Health News:Seeing Is Believing Does Not Hold Good For Color Perception 2Health News:A New Initiative To Fight Childhood Obesity 2
... Are Available In Two Models: One Is Direct ... Jaws Close. The Other Model Is Reverse ... Compressed The Jaws Open., ,The Forceps Are 22g, ... Through A 1.1mm Incision. These Forceps Allow The ...
... Allows Use Through A 1-Millimeter Incision.,Special ... Approach To The Incision.,Cystotome Tips Are ... Initiate And Complete A Circular Tear.,Titanium ... Improved Ergonomic Feel. Ideal For Bi-Manual ...
... fiber optic for homogenous illumination. ... bright halogen illumination for clear ... canal. Lithium-ion batteries with ... rheostat for fine control of ...
All Keeler otoscopes have bright halogen illumination for clear and accurate visualization of aural canal. Lithium-ion batteries with quick recharge capability. Ring rheostat for fine control of il...
Medicine Products: